$8.510
+0.174 (+2.04%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XGN Prediction & Forecast by Similar Chart Analysis
Alphio's XGN stock price prediction model matches the current Exagen Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.81 (+3.48%). The 1-week path is $9.23 (+8.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Exagen Inc Stock?
Exagen Inc is a good buy right now due to its current price of $8.39, which is significantly below the analyst price target of $12, indicating a potential upside of 43%. Additionally, the company reported a 16% year-over-year revenue growth in Q2 2026, reaching $19.9 million, and has raised its full-year revenue guidance to between $72 million and $75 million. However, the main risk is the negative net income, which was -$3.2 million in Q2 2026, indicating ongoing financial challenges that investors should consider.
XGN stock price ended at $8.51 on Wednesday, after rising +2.04%
Exagen Inc (XGN) last closed at $8.5100002, gaining +2.04%. These facts feed the 1-day and 1-week XGN price prediction above.
Forecast Drivers
Exagen Inc (XGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches XGN, ranked by similarity.
Seasonality analysis for XGN
Historically the probability of a positive November return for XGN is 100.00%. September offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.48 | $5.87 | $6.38 | -31.03% |
| Dec 2026 | $4.82 | $6.60 | $7.16 | -22.45% |
In 2026, Exagen Inc (XGN) is projected to range from $4.48 to $7.16.
Exagen Inc 2026 monthly forecast
In Nov 2026, Exagen Inc is projected to average $5.87, with a low of $4.48 and high of $6.38.
In Dec 2026, Exagen Inc is projected to average $6.60, with a low of $4.82 and high of $7.16.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.